{"count": 4, "results": [{"_id": "29411773", "pmid": 29411773, "title": "[A fixed-dose lisinopril+amlodipine+rosuvastatin combination: prospects for its use in patients with hypertension and concomitant dyslipidemia].", "journal": "Ter Arkh", "authors": ["Podzolkov VI", "Bragina AE", "Osadchiy KK"], "date": "2017-01-01T00:00:00Z", "doi": "10.17116/terarkh20178912133-140", "meta_date_publication": "2017", "meta_volume": "89", "meta_issue": "12", "meta_pages": "133-140", "score": 50065.062, "text_hl": "[A fixed-dose @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@+@CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@+@CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ combination: prospects for its use in @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and concomitant @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@].", "citations": {"NLM": "Podzolkov VI, Bragina AE, Osadchiy KK. [A fixed-dose lisinopril+amlodipine+rosuvastatin combination: prospects for its use in patients with hypertension and concomitant dyslipidemia]. Ter Arkh. 2017;89(12):133-140. PMID: 29411773", "BibTeX": "@article{29411773, title={[A fixed-dose lisinopril+amlodipine+rosuvastatin combination: prospects for its use in patients with hypertension and concomitant dyslipidemia].}, author={Podzolkov VI and Bragina AE and Osadchiy KK}, journal={Ter Arkh}, volume={89}, number={12}, pages={133-140}}"}}, {"_id": "12566371", "pmid": 12566371, "title": "Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies.", "journal": "Circulation", "authors": ["Ruggenenti P", "Mise N", "Pisoni R", "Arnoldi F", "Pezzotta A", "Perna A", "Cattaneo D", "Remuzzi G"], "date": "2003-02-04T00:00:00Z", "doi": "10.1161/01.cir.0000047526.08376.80", "meta_date_publication": "2003 Feb 4", "meta_volume": "107", "meta_issue": "4", "meta_pages": "586-92", "score": 50063.8, "text_hl": "METHODS AND RESULTS: In this longitudinal study, we evaluated the extent to which uptitration of the @GENE_AP2B1 @GENE_163 @@@ACE@@@ inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ to maximum tolerated doses (median [range]: 30 [10 to 40] mg/d) ameliorated @DISEASE_Proteinuria @DISEASE_MESH:D011507 @@@proteinuria@@@ and @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@ in 28 @SPECIES_9606 @@@patients@@@ with nondiabetic chronic @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@nephropathies@@@. ", "citations": {"NLM": "Ruggenenti P, Mise N, Pisoni R, Arnoldi F, Pezzotta A, Perna A, Cattaneo D, Remuzzi G. Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies. Circulation. 2003 Feb 4;107(4):586-92. PMID: 12566371", "BibTeX": "@article{12566371, title={Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies.}, author={Ruggenenti P and Mise N and Pisoni R and Arnoldi F and Pezzotta A and Perna A and Cattaneo D and Remuzzi G}, journal={Circulation}, volume={107}, number={4}, pages={586-92}}"}}, {"_id": "28294798", "pmid": 28294798, "title": "[Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease].", "journal": "Kardiologiia", "authors": ["Baranova EI", "Berezina AV", "Melioranskaya EI", "Polyakova EA"], "date": "2015-10-01T00:00:00Z", "doi": "10.18565/cardio.2015.10.68-75", "meta_date_publication": "2015 Oct", "meta_volume": "55", "meta_issue": "10", "meta_pages": "68-75", "score": 50046.883, "text_hl": "@SPECIES_9606 @@@PATIENTS@@@ AND METHODS: 6 months randomized study of fixed combination of amlodipin and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ with or without @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ of 20 @SPECIES_9606 @@@patients@@@ with 2 grade of arterial @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@ with @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@ and @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@nonalcoholic fatty liver disease@@@ (@DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@NAFLD@@@). ", "citations": {"NLM": "Baranova EI, Berezina AV, Melioranskaya EI, Polyakova EA. [Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease]. Kardiologiia. 2015 Oct;55(10):68-75. PMID: 28294798", "BibTeX": "@article{28294798, title={[Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease].}, author={Baranova EI and Berezina AV and Melioranskaya EI and Polyakova EA}, journal={Kardiologiia}, volume={55}, number={10}, pages={68-75}}"}}, {"_id": "27388615", "pmid": 27388615, "pmcid": "PMC4975815", "title": "Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy", "journal": "J Investig Med", "authors": ["Srivastava A", "Adams-Huet B", "Vega GL", "Toto RD"], "date": "2016-08-01T00:00:00Z", "doi": "10.1136/jim-2016-000102", "meta_date_publication": "2016 Aug", "meta_volume": "64", "meta_issue": "6", "meta_pages": "1102-8", "score": 50042.996, "text_hl": "We hypothesized that long-term administration of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ 100 mg or @CHEMICAL_Spironolactone @CHEMICAL_MESH:D013148 @@@spironolactone@@@ 25 mg once daily added onto @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ 80 mg once daily improves @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@DN@@@.", "citations": {"NLM": "Srivastava A, Adams-Huet B, Vega GL, Toto RD. Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy J Investig Med. 2016 Aug;64(6):1102-8. PMID: 27388615", "BibTeX": "@article{27388615, title={Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy}, author={Srivastava A and Adams-Huet B and Vega GL and Toto RD}, journal={J Investig Med}, volume={64}, number={6}, pages={1102-8}}"}}]}